RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results

RHÖN-KLINIKUM AG, a prominent healthcare provider in Germany, announced an encouraging start to the 2024 financial year, seeing increases in revenue, EBITDA, and consolidated profit during the first quarter. The company recorded revenues of €382.8 million, a 5.9% increase compared to €361.5 million in the first quarter of 2023. EBITDA improved to €25.2 million from €22.5 million, marking a 12% rise. The consolidated profit also climbed significantly to €11.1 million, up from €6.4 million in the previous year. This period saw 234,151 patients treated across the group's facilities, showing an uptick from 228,189 in Q1 2023.

Prof. Dr. Tobias Kaltenbach, Chairman of the Board of Management, expressed confidence in the group’s positioning ahead of expected hospital reform, highlighting the RHÖN Campus concept and expansion of outpatient services as strategic advantages. Looking forward, RHÖN-KLINIKUM AG reaffirms its 2024 revenue projection of around €1.6 billion, with anticipated EBITDA between €110 million and €120 million, though it noted potential risks from regulatory changes and ongoing global crises.